Inside Washington: AIDS Prevention Campaign Spotlights Biotech

February 15, 2003
Jill Wechsler
Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-02-01-2003, Volume 16, Issue 2

by Jill Wechsler Efforts to move vaccines from test stage to commercial production are raising concerns about manufacturing capacity.

Related Content:

Using Amino Acid Analysis to Determine Absorptivity Constants: A Validation Case Study Using Bovine Serum Albumin